Synergistic Soft Tissue Defect Reconstruction System

A novel system integrating a segmented skirted surgical mesh with AI, IoT, blockchain, and advanced materials to enhance soft tissue defect reconstruction outcomes, streamline data management, and improve patient care.

The original segmented skirted surgical mesh patent addresses soft tissue defect reconstruction, but it has limitations in terms of mesh configuration optimization, data tracking, and material properties. The new inventive concept overcomes these limitations by combining the patented mesh with cutting-edge technologies.

The synergistic system comprises a segmented skirted surgical mesh, a machine learning algorithm for predicting optimal mesh configuration, a blockchain-based platform for secure data storage and tracking, an IoT-enabled sensor for real-time mesh deformation monitoring, and a novel material composition with enhanced tensile strength. The AI-powered design software generates customized mesh configurations based on patient-specific data, which are then manufactured using 3D printing technology.

The new claims introduce the innovative integration of distinct technologies, creating a more powerful system that significantly improves soft tissue defect reconstruction outcomes, data management, and patient care. The inventive step lies in the synergistic combination of these technologies, which provides a non-obvious solution to the limitations of the original patent.

Alternative embodiments may include variations in mesh material composition, AI algorithm designs, blockchain platform implementations, and IoT sensor configurations. The inventive concept can be adapted for different types of soft tissue defects, patient populations, and surgical procedures.

The synergistic soft tissue defect reconstruction system has significant commercial potential in the medical device and healthcare industries, targeting markets such as abdominal hernia repair, pelvic floor reconstruction, and tissue engineering.